FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and ...

Abrysvo is the first vaccine for the respiratory syncytial virus that is indicated for adults younger than 50, the drugmaker ...

Activist hedge fund Starboard Value's chief investment officer Jeffrey Smith said on Tuesday that drugmaker Pfizer Inc's ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) ...

Merck presents positive results from phase 2b/3 trial of clesrovimab, an investigational RSV preventative monoclonal antibody at IDWeek 2024: Rahway, New Jersey Saturday, October ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

DHHS says that influenza, COVID-19 and respiratory syncytial virus (RSV) are expected to increase over the coming weeks.

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you ...

RTE presenter Kathryn Thomas has opened up about her daughter's brush with the potentially deadly respiratory syncytial virus (RSV) virus to make other parents aware. Kathryn said the incident ...